164 related articles for article (PubMed ID: 2560687)
1. Corticotrophin-like intermediary lobe peptide as a marker of alternate pro-opiomelanocortin processing in ACTH-producing non-pituitary tumours.
Vieau D; Massias JF; Girard F; Luton JP; Bertagna X
Clin Endocrinol (Oxf); 1989 Dec; 31(6):691-700. PubMed ID: 2560687
[TBL] [Abstract][Full Text] [Related]
2. ACTH LPH and related peptides in the ectopic ACTH syndrome.
Pullan PT; Clement-Jones V; Corder R; Lowry PJ; Besser GM; Rees LH
Clin Endocrinol (Oxf); 1980 Nov; 13(5):437-45. PubMed ID: 6261991
[TBL] [Abstract][Full Text] [Related]
3. Pro-opiocortin related peptides in human pituitary and ectopic ACTH secreting tumours.
Ratter SJ; Gillies G; Hope J; Hale AC; Grossman A; Gaillard R; Cook D; Edwards CR; Rees LH
Clin Endocrinol (Oxf); 1983 Mar; 18(3):211-8. PubMed ID: 6305538
[TBL] [Abstract][Full Text] [Related]
4. Expression of the neuroendocrine cell marker 7B2 in human ACTH secreting tumours.
Vieau D; Linard CG; Mbikay M; Lenne F; Chretien M; Luton JP; Bertagna X
Clin Endocrinol (Oxf); 1992 Jun; 36(6):597-603. PubMed ID: 1424185
[TBL] [Abstract][Full Text] [Related]
5. The pituitary V3 vasopressin receptor and the corticotroph phenotype in ectopic ACTH syndrome.
de Keyzer Y; Lenne F; Auzan C; Jégou S; René P; Vaudry H; Kuhn JM; Luton JP; Clauser E; Bertagna X
J Clin Invest; 1996 Mar; 97(5):1311-8. PubMed ID: 8636444
[TBL] [Abstract][Full Text] [Related]
6. Chromatographic characteristics of pro-opiomelanocortin-derived peptides from the rat transplantable tumour 7315a.
Morano MI; Estivariz FE
J Endocrinol; 1987 Mar; 112(3):417-25. PubMed ID: 3031191
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylated forms of adrenocorticotropin and corticotropin-like intermediary lobe peptide in human tumors.
Massias JF; Hardouin S; Vieau D; Lenne F; Bertagna X
Eur J Endocrinol; 1994 Oct; 131(4):341-6. PubMed ID: 7921221
[TBL] [Abstract][Full Text] [Related]
8. Regional distribution of pro-opiomelanocortin-derived peptides in the human brain.
Emson PC; Corder R; Ratter SJ; Tomlin S; Lowry PJ; Ress LH; Arregui A; Rosser MN
Neuroendocrinology; 1984 Jan; 38(1):45-50. PubMed ID: 6320029
[TBL] [Abstract][Full Text] [Related]
9. Neuroendocrine alterations in nude mice with a human lung carcinoma producing pro-opiomelanocortin, corticotrophin-releasing hormone and arginine vasopressin.
Morano MI; de Antueno RJ; Niedfeld G; Estivariz FE
Clin Endocrinol (Oxf); 1990 Mar; 32(3):349-62. PubMed ID: 2160874
[TBL] [Abstract][Full Text] [Related]
10. 60 YEARS OF POMC: Purification and biological characterisation of melanotrophins and corticotrophins.
Lowry P
J Mol Endocrinol; 2016 May; 56(4):T1-T12. PubMed ID: 26643914
[TBL] [Abstract][Full Text] [Related]
11. Gamma-melanotrophin-like immunoreactivities in human pituitaries, ACTH-producing pituitary adenomas, and ectopic ACTH-producing tumours: evidence for an abnormality in glycosylation in ectopic ACTH-producing tumours.
Tanaka I; Nakai Y; Nakao K; Oki S; Fukata J; Imura H
Clin Endocrinol (Oxf); 1981 Oct; 15(4):353-61. PubMed ID: 6274545
[TBL] [Abstract][Full Text] [Related]
12. Expression of the prohormone convertase PC2 correlates with the presence of corticotropin-like intermediate lobe peptide in human adrenocorticotropin-secreting tumors.
Vieau D; Seidah NG; Mbikay M; Chrétien M; Bertagna X
J Clin Endocrinol Metab; 1994 Nov; 79(5):1503-6. PubMed ID: 7962350
[TBL] [Abstract][Full Text] [Related]
13. Characterization of pro-opiomelanocortin-derived peptides in pituitary and ectopic adrenocorticotrophin-secreting tumours.
Hale AC; Besser GM; Rees LH
J Endocrinol; 1986 Jan; 108(1):49-56. PubMed ID: 3003221
[TBL] [Abstract][Full Text] [Related]
14. Proopiolipomelanocortin peptides in normal pituitary, pituitary tumor, and plasma of normal and Cushing's horses.
Wilson MG; Nicholson WE; Holscher MA; Sherrell BJ; Mount CD; Orth DN
Endocrinology; 1982 Mar; 110(3):941-54. PubMed ID: 6276164
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of vasopressin (V3) and corticotrophin-releasing hormone receptor genes in corticotroph tumours.
de Keyzer Y; René P; Beldjord C; Lenne F; Bertagna X
Clin Endocrinol (Oxf); 1998 Oct; 49(4):475-82. PubMed ID: 9876345
[TBL] [Abstract][Full Text] [Related]
16. A case of pituitary dependent Cushing's disease with clinical and biochemical features of the ectopic ACTH syndrome.
Hale AC; Millar JB; Ratter SJ; Pickard JD; Doniach I; Rees LH
Clin Endocrinol (Oxf); 1985 Apr; 22(4):479-88. PubMed ID: 2985302
[TBL] [Abstract][Full Text] [Related]
17. [Synthesis and release of CRF and ACTH in ectopic CRF/ACTH-producing tumors].
Suda T
Nihon Naibunpi Gakkai Zasshi; 1994 Jan; 70(1):17-24. PubMed ID: 7958079
[TBL] [Abstract][Full Text] [Related]
18. Pars intermedia peptides: studies in adult humans.
Ratter SJ; McLoughlin L; Gillies G; Clement-Jones V; Hope J; Rees LH
Ciba Found Symp; 1981; 81():224-43. PubMed ID: 6268379
[TBL] [Abstract][Full Text] [Related]
19. Post-translational processing of pro-opiomelanocortin (POMC)-derived peptides during fetal monkey pituitary development. I. Adrenocorticotropin (ACTH) and alpha-melanotropins (alpha-MSHs).
Allen RG; Hatfield JM; Stack J
Dev Biol; 1988 Mar; 126(1):156-63. PubMed ID: 2830157
[TBL] [Abstract][Full Text] [Related]
20. Altered proopiomelanocortin gene expression in adrenocorticotropin-producing nonpituitary tumors. Comparative studies with corticotropic adenomas and normal pituitaries.
de Keyzer Y; Bertagna X; Lenne F; Girard F; Luton JP; Kahn A
J Clin Invest; 1985 Nov; 76(5):1892-8. PubMed ID: 2997296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
